Filing Details

Accession Number:
0000899243-20-003410
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-05 20:22:26
Reporting Period:
2020-02-03
Accepted Time:
2020-02-05 20:22:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552451 Myokardia Inc MYOK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413822 Anastasios Gianakakos C/O Myokardia, Inc.
333 Allerton Avenue
South San Francisco CA 94080
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-02-03 4,000 $69.27 87,777 No 4 S Direct
Common Stock Disposition 2020-02-03 1,000 $69.74 86,777 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 225,947 Indirect By Reporting Person's Trust 2
Common Stock 323,526 Indirect By Reporting Person's Trust 3
Common Stock 12,200 Indirect By Trust 1
Common Stock 12,200 Indirect By Trust 2
Common Stock 12,200 Indirect By Trust 3
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Represents the weighted average sale price of the shares sold ranging from $68.55 to $69.54 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Represents the weighted average sale price of the shares sold ranging from $69.57 to $69.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.